Category: Issues

Welcome to the Q2 edition of Global Health & Pharma Magazine 2022, providing you with all of the latest news and features from across the healthcare and pharmaceutical landscape.

We are always in need of scientific developments. With a plethora of diseases, conditions, and medical issues in general, we require the rapid progress of remedies and cures. From medicine to devices, the most important thing is that we become more vigilant and resilient with our inventions, preventions, and ways of living our lives.

In this issue we explore some practices, firms, and companies that are using their sheer intellect and highly professional attitude to change the medical sphere. From innovative dental care to intricate surgery, medical device development to exceptional biotechnology, and much more, this issue of GHP is looking at a variety of businesses that are altering the way we see healthcare and medicine as a whole.

All of us at GHP wish you very prosperous and fulfilling times ahead and we look forward to delivering Q3 to you soon.

Welcome to the Q1 edition of Global Health & Pharma Magazine 2022, providing you with all of the latest news and features from across the healthcare and pharmaceutical landscape.

With tensions continuing to build around the globe, we can see an influx of individuals and businesses that promote togetherness. Here we can see the building blocks to a better future in health and research to overcome some of life’s greatest challenges.

It is this togetherness that ensures safe spaces for people everywhere – mentally, physically, and emotionally. We experience these medical developments in a way that changes our perception of good health as well as our relationships with our bodies.

In this issue we see the present and future of testing, holistic wellness, luxury training facilities, nutritional ingredient solutions, and much more. With skilled and revolutionary clinics that are leaders in their industry; we open, continue, and finish strong throughout this entire issue.

These excellent success stories show us more beneficial treatments and health services than ever before. We have been in touch with many companies, across an assortment of sectors, that are researching and enforcing new ways of curing, testing, and supporting people all over the world.

For example, The Whiteley Clinic’s treatments in the field of phlebology has propelled it to a point of great success. With its blood research abilities and passion, it has been changing the course of healthcare.

As spring swiftly approaches us, we at GHP wish you a very happy March. We look forward to seeing you again for Q2.

Welcome to the 2021 Q4 edition of Global Health & Pharma Magazine, providing you with all the latest news and features from across the healthcare and pharmaceutical landscape.

The last couple of years have witnessed a wide variety of businesses, across multiple industries, flourish and thrive even in the face of adversity. However, here we can see a selection of particularly innovative and focused businesses that have astonishingly excelled throughout the global pandemic.

For instance, our cover company Smart Blood Analytics have introduced two fine products that have altered the way we diagnose illnesses. This experienced Swiss business harnesses the power of Artificial Intelligence to detect any current or future defects within the blood. This is an invaluable service that can ultimately conquer the late diagnosis of serious illness and disease. With developments like this we can look towards the future with confidence.

Join us as we delve deeper into many other successful business stories that have not only stood the test of time, but that have grown exponentially throughout some of the darkest days. As usual, we hope you enjoy this issue and we look forward to seeing you again for Q1 2022.

Welcome to the 2021 Q3 edition of Global Health & Pharma Magazine, providing you with all the latest news and features from across the healthcare and pharmaceutical landscape.

As we come towards the final quarter of a second year shaped by a global pandemic, we might be excused for thinking only on the exceptional work around Covid-19 when reflecting on the successes achieved by the healthcare and pharmaceutical industries this year. However, over the last quarter, the global companies within these vital sectors have remained just as – if not more – busy with endeavours outside the pandemic as well.

From the development of lasers and their expanding capabilities being championed by our cover company for this month, Erchonia Lasers, to the ground-breaking personalisation technology within breast cancer treatment being developed by DCISionRT, to the many other stories of exceptional and transformational work exhibited in this issue of GHP Magazine, it is clear that the global health and pharmaceutical industry has a lot to be proud of this quarter.

Thus, we invite you to dive in and discover more about these fantastic companies and their life-changing work – whether it be in aesthetic treatments or surgical procedures, pharmaceutical innovations or the enhanced services. We hope you enjoy this issue of GHP Magazine, and wish you safe and well until we meet again in the Q4 edition.

Welcome to the 2021 Q2 edition of Global Health & Pharma Magazine, providing you with all the latest news and features from across the healthcare and pharmaceutical landscape.

While the last eighteen months have seen all industries demonstrating resilience and versatility in a period defined by adversity, few have matched the exceptional work of the global healthcare and pharmaceutical industries. These impressive feats are by no means limited to successful vaccine programme rollouts or treatment of Covid-19 cases – as individuals have become more aware of the importance of caring for our general physical and mental wellbeing during the pandemic, organisations across the industry have seen demand for their products and services soar.

That is certainly the case for the companies included in this quarter’s edition of GHP, including our cover company, BioMin Technologies, a leading researcher into dental sensitivity and developer of sensitivity relief and prevention products. We find out how this London-based start-up has grown since 2015 and plans to build on the momentum generated in online sales during the pandemic to see further growth that facilitates exciting advanced research into dental sensitivities.

Join us as we explore many of the other success stories to come out of this vibrant and valued industry over the past few months. Until the next issue of GHP, we wish you all the best for the months ahead.

Welcome to the 2021 Q1 edition of Global Health & Pharma Magazine, providing you with all the latest news and features from across the healthcare and pharmaceutical landscape.

Whilst 2020 may have proven to be a very difficult year for many, the healthcare and pharmaceutical industry was certainly pushed to its limits. Yet, just over twelve months on from the start of the pandemic and national lockdowns, there is sign of reprieve and hope that life can begin again. The rollout of vaccines in the fight against COVID-19 has proven to be a success, healthcare and pharmaceutical staff have given everything to help others, and the world is slowly but surely showing signs of returning to normal.

Speaking of returning to normal, many people will be yearning to get back to their hairdresser or barber and see to it that their hair is restored to its former glory. For those who have struggled with hair loss, be it genetic or simply pulling it out at the thought of an extended lockdown , the work of Juvida Clinics represents the same kind of hope for people who want their hair back. Juvida Clinics may not be able to bring back the last twelve months, but it can inspire youthfulness and life in its clients, helping them get ready for a return to life as normal with friends and family.

There is plenty more success stories such as this one to unpack within these pages, with each company featured delivering its own success through insightful knowledge and fantastic innovation in abundance. For now, we hope that you are staying safe and enjoy reading this latest issue of Global Health & Pharma.